Kintara Therapeutics enters into $2.85M ATM sales agreement with A.G.P.

TuHURA Biosciences, Inc./NV

Up to $2.85M of common stock may be offered and sold from time to time via Agent A.G.P./Alliance Global Partners.
Agent receives 3.0% commission on gross proceeds; Company reimburses up to $50,000 in initial expenses.
Initially reserved 685,096 shares based on $4.16 closing price on Sep 15, 2023.
Sales may be made on Nasdaq Capital Market as 'at-the-market' under Rule 415; Company not obligated to sell.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

TuHURA Biosciences, Inc./NV entered into Sales Agreement with A.G.P./Alliance Global Partners valued at $2.85 million (effective 2023-09-19).

Action: entry
Agreement: atm program
Counterparty: A.G.P./Alliance Global Partners
Value: $2.85 million
Effective: 2023-09-19

Exact text from the filing

On September 19, 2023, Kintara Therapeutics, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Agent”) pursuant to which the Company may offer and sell, from time to time, through the Agent, as sales agent and/or principal, shares of its common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $2.85 million (“Shares”), subject to certain limitations on the amount of Common Stock that may be offered and sold by the Company set forth in the Sales Agreement (the “Offering”).

View on SEC.gov

75 material agreements filed in the last 30 days. Browse all material agreements →

TuHURA Biosciences, Inc./NV filing history →

Source: SEC EDGAR

accession 0000950170-23-048785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.